Nerviano Medical Sciences is part of NMS Group and it is focused on the discovery and early development of oncology drugs. Our business model is to partner our drugs at late preclinical or early clinical stage for full development and commercialization. 

Our mission is to pursue innovative therapeutic approaches in Oncology, discovering and developing molecules with novel mechanisms of action, for the advancement of personalized care of cancer patients. An experienced and lean management team leads a highly skilled staff of professionals with international experience and a broad range of expertise in R&D, combining the flexibility of a biotech with the quality standards of a big pharma.

Biotechnology

Life Sciences

Therapeutics

Nerviano Medical Sciences

Hugues Dolgos

Terrence West

Davide Martin Marchetti

Sidney Dung

Antonella Isacchi

Rosita Lupi

Alessia Montagnoli

The Leadership Team at Nerviano Medical Sciences provides strategic direction and oversight to ensure the successful discovery and development of innovative oncology drugs. Comprising the Chairperson of the Board and CEO, the Global Head Of Asset Leadership, and dual Chief Operating Officers, this team coordinates efforts across R&D, manages key partnerships, and drives the company's mission to advance personalized cancer care through cutting-edge therapeutic approaches.

Leadership Team

Research and Data Management

Leadership Team

About

Team members

Other teams at Nerviano Medical Sciences

Research and Data Management